249 related articles for article (PubMed ID: 34019288)
1. MYC Analysis in Cancer and Evolution.
Hartl M; Bister K
Methods Mol Biol; 2021; 2318():87-117. PubMed ID: 34019288
[TBL] [Abstract][Full Text] [Related]
2. Analyzing Myc in cell transformation and evolution.
Hartl M; Bister K
Methods Mol Biol; 2013; 1012():21-49. PubMed ID: 24006056
[TBL] [Abstract][Full Text] [Related]
3. MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.
Stefan E; Bister K
Curr Top Microbiol Immunol; 2017; 407():117-151. PubMed ID: 28466200
[TBL] [Abstract][Full Text] [Related]
4. Measuring MYC-Mediated Metabolism in Tumorigenesis.
Tang HY; Goldman AR; Zhang X; Speicher DW; Dang CV
Methods Mol Biol; 2021; 2318():231-239. PubMed ID: 34019293
[TBL] [Abstract][Full Text] [Related]
5. MYC, metabolism, cell growth, and tumorigenesis.
Dang CV
Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906881
[TBL] [Abstract][Full Text] [Related]
6. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
[TBL] [Abstract][Full Text] [Related]
7. Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers.
Vízkeleti L; Spisák S
Cells; 2023 Jun; 12(13):. PubMed ID: 37443779
[TBL] [Abstract][Full Text] [Related]
8. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain.
Hoang AT; Lutterbach B; Lewis BC; Yano T; Chou TY; Barrett JF; Raffeld M; Hann SR; Dang CV
Mol Cell Biol; 1995 Aug; 15(8):4031-42. PubMed ID: 7623799
[TBL] [Abstract][Full Text] [Related]
9. An avian retrovirus expressing chicken pp59c-myc possesses weak transforming activity distinct from v-myc that may be modulated by adjacent normal cell neighbors.
Filardo EJ; Humphries EH
J Virol; 1991 Dec; 65(12):6621-9. PubMed ID: 1942247
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Schaub FX; Dhankani V; Berger AC; Trivedi M; Richardson AB; Shaw R; Zhao W; Zhang X; Ventura A; Liu Y; Ayer DE; Hurlin PJ; Cherniack AD; Eisenman RN; Bernard B; Grandori C;
Cell Syst; 2018 Mar; 6(3):282-300.e2. PubMed ID: 29596783
[TBL] [Abstract][Full Text] [Related]
11. Structure and transforming function of transduced mutant alleles of the chicken c-myc gene.
Patschinsky T; Jansen HW; Blöcker H; Frank R; Bister K
J Virol; 1986 Aug; 59(2):341-53. PubMed ID: 3016301
[TBL] [Abstract][Full Text] [Related]
12. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
[TBL] [Abstract][Full Text] [Related]
13. Myc coordinates transcription and translation to enhance transformation and suppress invasiveness.
Elkon R; Loayza-Puch F; Korkmaz G; Lopes R; van Breugel PC; Bleijerveld OB; Altelaar AF; Wolf E; Lorenzin F; Eilers M; Agami R
EMBO Rep; 2015 Dec; 16(12):1723-36. PubMed ID: 26538417
[TBL] [Abstract][Full Text] [Related]
14. MYC the oncogene from hell: Novel opportunities for cancer therapy.
Papadimitropoulou A; Makri M; Zoidis G
Eur J Med Chem; 2024 Mar; 267():116194. PubMed ID: 38340508
[TBL] [Abstract][Full Text] [Related]
15. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
[No Abstract] [Full Text] [Related]
16. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
17. Translocations involving c-myc and c-myc function.
Boxer LM; Dang CV
Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
[TBL] [Abstract][Full Text] [Related]
18. The brain acid-soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulin.
Hartl M; Puglisi K; Nist A; Raffeiner P; Bister K
Mol Oncol; 2020 Mar; 14(3):625-644. PubMed ID: 31944520
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional control of DNA replication licensing by Myc.
Valovka T; Schönfeld M; Raffeiner P; Breuker K; Dunzendorfer-Matt T; Hartl M; Bister K
Sci Rep; 2013 Dec; 3():3444. PubMed ID: 24309437
[TBL] [Abstract][Full Text] [Related]
20. Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation.
Tikhonenko AT; Hartman AR; Linial ML
Mol Cell Biol; 1993 Jun; 13(6):3623-31. PubMed ID: 8497274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
